<DOC>
	<DOCNO>NCT03047668</DOCNO>
	<brief_summary>Basic treatment type 2 diabetes focus diet , physical activity lifestyle . Nevertheless , early late stage T2DM , lifestyle intervention mostly substitute pharmacological intervention , although lifestyle modification dietary treatment would favourable . The researcher therefore investigate dietary strategy low-carb very-low calory diet regard potential improve metabolism body weight ( mostly ) long-term T2DM patient . This core comparison deal DiNA-D study ( publish elsewhere ) . POLYPHEM target specific dietary approach preserve achieve metabolic improvement DiNA-D phase 1 . Nutritional factor PUFAs BCAAs .</brief_summary>
	<brief_title>POLY-unsaturated Fatty Acids Preservation Dietary Effects Hepatosteatosis Energy Metabolism Type 2 Diabetes</brief_title>
	<detailed_description>Basic treatment type 2 diabetes focus diet , physical activity lifestyle . Nevertheless , early late stage T2DM , lifestyle intervention mostly substitute pharmacological intervention , although lifestyle modification dietary treatment would favourable . The researcher therefore investigate dietary strategy low-carb very-low calory diet regard potential improve metabolism body weight ( mostly ) long-term T2DM patient . This core comparison deal DiNA-D study ( publish elsewhere ) . POLYPHEM target specific dietary approach preserve achieve metabolic improvement DiNA-D phase 1 . Nutritional factor maintenance period within DiNA-D ( 11 month ) PUFAs BCAAs , provide walnuts custom-made muffin contain walnut , sunflower oil isomaltulose .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>male female subject 1879 year old type 2 diabetes renal insufficiency anaemia immunosuppression previous symptomatic cancer diagnosis acute cardiovascular disease ( stroke , coronary syndrome ) pregnancy lactation severe psychiatric disorder corticoid immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>